Type 2 Diabetes

A discussion on using continuous glucose monitoring systems to improve the management of type 2 diabetes.

The benefits of using new therapies, such as SGLT2 inhibitors and GLP-1 receptor agonists, to treat type 2 diabetes.

Guidance on the use of aspirin therapy in patients at risk of cardiovascular events, based on recently updated guideline recommendations.

Considerations that factor into decisions for reducing LDL levels in patients with diabetes with statin therapy or options, such as PCSK9 inhibitors and ezetimibe.

A call to action for more focus on the management of the type 2 diabetes epidemic around the globe.

A study presented at RSNA 2021 suggests sonographic quantitative assessment of the deltoid muscle could provide a simple and noninvasive screening method for detection of type 2 diabetes.

An analysis of Medicare fee-for-service data from 2017-2019 details the widening gaps in access to newer diabetes technologies for non-White patients in the US.

A retrospective analysis of data from more than 170 patients with Cushing syndrome and hyperglycemia provides insight into the effects of curative treatment on hyperglycemia among these patients.

An analysis of patient data from the EDICT study demonstrates the potential benefit of triple therapy in patients with new-onset type 2 diabetes.

The Practical Cardiology editorial staff has compiled a list of 6 noteworthy posters related to cardiology from the Metabolic Institute of America's 19th annual World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease.

Analysis of data from the SOS study indicates bariatric surgery was associated with a 37% reduction in incident cancer among individuals with obesity and diabetes versus conventional obesity treatments, with those achieving diabetes remission experiencing a 60% reduction in risk.

After a weekend of discussions and presentations, Endocrinology Network's editorial staff has compiled a list of 6 noteworthy posters presented at TMIOA's 19th annual WCIRDC.

Fish oil intervention and DASH diet show no statistically significant effect on glycemic control and adiposity.

With TMIOA hosting the 19th Annual World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease, the Endocrinology Network editorial staff has compiled a list of 5 noteworthy posters presented at the conference.

Participants with diabetes mellitus specifically were more prone to develop insulin resistance due to BPA exposure as compared to non-diabetic participants

A 31-person task force has composed and released new multispecialty recommendations for management and diagnosis of diabetes and cardiometabolic disease.

A 31-person task force has composed and released new multispecialty recommendations for management and diagnosis of diabetes and cardiometabolic disease.

Of the 416 basal insulin initiators, only one-third of them reached the appropriate fasting blood glucose level.

Dr. Zeitler highlights the long-term microvascular risk complications observed in T2D patients in the TODAY2 observational study.

These reductions, investigators noted, were slightly greatest yet not statistically significant.

The DCRM Task Force recommendations were described as first-of-its-kind guidance for patients with overlapping diabetic, cardiorenal and metabolic disease.

Expert clinicians discuss insulin therapy for treating type 2 diabetes and comment on what to look forward to in the future of diabetes care.

Drs Dennis Bruemmer and Jennifer Green review recent trial data on a novel combination of GIP and GLP1 receptor agonists to treat type 2 diabetes.

A Mayo Clinic-led retrospective analysis suggests patients with T2D had an 88% greater risk of developing any diabetic retinopathy within the first 15 years of diagnosis compared to those with T1D.

Patients with type 2 diabetes treated with triple therapy had less hepatic steatosis and fibrosis and significantly improved insulin sensitivity versus conventional therapy.